|
|
Genome-wide association studies and other forms of genome-phenome correlation require
large numbers of individuals to achieve statistical validity and robustness, especially
for complex traits. To support these kinds of studies across a broad range of human
conditions, Vanderbilt has launched a biobank of DNA samples extracted from left-over
blood after clinical testing for all patients who do not choose to opt-out of the
collection. Samples are de-identified and linked to a 'synthetic derivative' database
of de-identified data derived from electronic medical records. This presentation
will outline the bioinformatics infrastructure and challenges associated with creation
of a large scale de-identified genome-phenome correlation resource.
|
|